Sowmya has an impressive background in cell biology and molecular genetics with a focus on human genetics and biomarker studies. Her educational journey includes a BSc and MSc in Human Genetics from India, as well as a PhD in cell biology and molecular genetics from the University of Salford,
Manchester, UK. During her doctoral research, she explored miRNA-based molecular biomarkers for E liquid associated lung injury (EVALI) resulting from vaping.
Following her PhD, Sowmya transitioned to the industry, where she worked as a biomarker scientist. In this role, she contributed to the development of assays for biomarkers associated with neurodegenerative diseases like Alzheimer’s, Parkinson’s, and MSA. Her expertise extends to creating pharmaceutical assays for various disorders, including oncology and neurodegenerative diseases.
Sowmya’s current focus at Functional Gut is directed toward research related to gut-related disorders,
such as intestinal permeability, irritable bowel syndrome (IBS), and gastrointestinal diseases. She aims to introduce innovative methodologies and diagnostics to enhance our understanding of the gut biome’s functioning.